Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2018-12-10 Director's Dealing
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2018-12-10 English
FORM 4
Director's Dealing
2018-11-14 English
10-Q
Interim / Quarterly Report Q3 2018
2018-11-06 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key content is Item 2.02 "Results of Operations and Financial Condition," indicating the company reported earnings for the third quarter ended September 30, 2018. The document includes a press release as Exhibit 99.1 with financial results highlights. The document length is 3295 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than a full detailed financial report. According to the rules, initial announcements of quarterly financial results with key highlights only are classified as Earnings Release (ER). The document is not a full quarterly report (IR) because it lacks comprehensive financial statements or substantive financial data and analysis. Therefore, the correct classification is Earnings Release (ER).
2018-11-06 English
Regulatory Filings 2018
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, form names, fiscal period dates, or document titles that can be used to identify the filing type. The text is not a typical financial report or announcement and lacks substantive financial data or narrative. Given the absence of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS).
2018-11-01 English
FORM 4
Director's Dealing
2018-10-30 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.